Pharmaceutical composition comprising an inhibitor and an Insulin sglt2； and use for treating a disease or condition such as diabetes mellitus, Type 1 and 2 diabetes mellitus, among others.
MARK MICHAEL,KLEIN THOMAS,GREMPLER, ROLF,JOHANSEN ODD-ERIK,LUIPPOLD GERD
申请号：
CL2013001104
公开号：
CL2013001104A1
申请日:
2013.04.22
申请国别(地区):
CL
年份:
2013
代理人:
摘要：
The invention relates to a pharmaceutical composition according to the claim 1 comprising an SGLT2 inhibitor and an insulin which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditionsUSO DE UNA COMBINACIÓN FARMACÉUTICA QUE COMPRENDE A) EL INHIBIDOR DE SGLT2 (1-CLORO-4-(B-DGLUCOPIRANOS-1 -IL)-2-[4-((S)-TETRAHIDROFURAN-3-ILOXI)- BENCIL]-BENCENO, Y B) UNA INSULINA PARA TRATAR UNA ENFERMEDAD O AFECCIÓN TAL COMO DIABETES MELLITUS, DIABETES MELLITUS TIPO 1 Y 2. ENTRE OTRAS.
